Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population

Abstract

Objective

Recent data indicate that Toll-like receptors (TLRs) participate in various neuropathologic conditions, including ictogenesis, myelin disruptions associated with chronic alcohol abuse, behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage, and activation of microglia to reduce amyloid β deposits. As seizures and depression are well known neuropsychiatric syndromes in systemic lupus erythematosus (SLE) the aim of the study was to investigate whether TLR4 gene polymorphism 1196C/T (rs4986791, Thr399Ile) was a candidate for susceptibility of development of neuropsychiatric systemic lupus erythematosus (NPSLE).

Methods

The study covered 60 patients with SLE and 100 healthy individuals. TLR4 1196C/T genotyping was performed by real-time polymerase chain reaction with the SimpleProbe.

Results

The SLE group comprised 86.7% of patients with wild-type homozygotes CC and 13.3% heterozygotes CT and no homozygotes TT. The control group consisted of 85% wild-type homozygotes CC, 15% heterozygotes CT and no homozygotes TT. The frequencies of genotype and allele distribution in SLE patients did not differ significantly from those of the control subjects. The probability of describing the possible risk of SLE imputed to genotype did not significantly differ in comparison with the healthy individuals (p = 0.77, odds ratio = 0.87, 95% confidence interval 0.34–2.19). A significant genotype association of genotype CC with arthritis was found in SLE patients (p = 0.02). It was further confirmed by a significant association of a dominant allele C with arthritis (p = 0.02). No association between CC and CT genotypes of TLR4 1196C/T and NPSLE was found. Allele distribution of TLR4 1196C/T also was not associated with NPSLE. No other significant differences were found in genotype and allele frequencies regarding clinical manifestation of SLE patients.

Conclusion

In the Polish population of SLE patients, 1196C/T polymorphism of TLR4 gene does not increase the risk of development of NPSLE; however, genotype CC and a dominant allele C is associated with arthritis in the course of SLE.

Keywords

Systemic lupus erythematosus neuropsychiatric lupus Toll-like receptor

Get full access to this article

View all access options for this article.

References

Hashimoto

Hudson

Anderson

. The Toll gene of drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988; 52: 269–279.

Medzhitov

Preston-Hurlburt

Janeway

Jr . A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394–397.

Richez

Blanco

Rifkin

Moreau

Schaeverbeke

. Role for toll-like receptors in autoimmune disease: The example of systemic lupus erythematosus. Joint Bone Spine 2011; 78: 124–130.

Olson

Miller

. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004; 173: 3916–3924.

Bowman

Rasley

Tranguch

Marriott

. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003; 43: 281–291.

Bsibsi

Ravid

Gveric

van Noort

. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002; 61: 1013–1021.

Leow-Dyke

Allen

Denes

. Neuronal toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro. J Neuroinflammation 2012; 9: 230–230.

O'Neill

Bryant

Doyle

. Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev 2009; 61: 177–197.

Maroso

Balosso

Ravizza

. Toll-like receptor 4 and high–mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010; 16: 413–419.

10.

Alfonso-Loeches

Pascual

Gómez-Pinedo

Pascual-Lucas

Renau-Piqueras

Guerri

. Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse. Glia 2012; 60: 948–964.

11.

Pascual

Baliño

Alfonso-Loeches

Aragón

Guerri

. Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage. Brain Behav Immun 2011; 25(Suppl. 1): 80–91.

12.

Song

Jin

Lim

Kou

Pattanayak

Rehman

. TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease. J Neuroinflammation 2001; 8: 92–92.

13.

Sánchez

Orozco

López-Nevot

Jiménez-Alonso

Martín

. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004; 63: 54–57.

14.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

15.

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599–608.

16.

Moser

Kelly

Lessard

Harley

. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009; 10: 373–379.

17.

Harley

Kaufman

Langefeld

Harley

Kelly

. Genetic susceptibility to SLE: New insights from fine mapping and genome-wide association studies. Nat Rev Genet 2009; 10: 285–290.

18.

Sabroe

Prince

Jones

. Selective roles for Toll-like receptor (TLR) 2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 2003; 170: 5268–5275.

19.

Sandig

Bulfone-Paus

. TLR signaling in mast cells: Common and unique features. Front Immunol 2012; 3: 185–185.

20.

Eriksson

Meadows

Basu

Mselle

Wira

Sentman

. TLRs mediate IFN-gamma production by human uterine NK cells in endometrium. J Immunol 2006; 176: 6219–6224.

21.

Olson

Miller

. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004; 173: 3916–3924.

22.

Bowman

Rasley

Tranguch

Marriott

. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003; 43: 281–291.

23.

Noreen

Shah

Mall

Choudhary

Hussain

Ahmed

. TLR4 polymorphisms and disease susceptibility. Inflamm Res 2012; 61: 177–188.

24.

Popescu

Kao

. Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol 2011; 9: 449–457.

25.

Kutikhin

. Impact of Toll-like receptor 4 polymorphisms on risk of cancer. Hum Immunol 2011; 72(2): 193–206.

26.

Ferwerda

McCall

Alonso

Giamarellos-Bourboulis

Mouktaroudi

Izagirre

. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A 2007; 104: 16645–16650.

27.

Rallabhandi

Bell

Boukhvalova

. Analysis of TLR4 polymorphic variants: New insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 2006; 177: 322–332.

28.

Lee

Bae

Song

. Meta-analysis demonstrates association between TLR polymorphisms and rheumatoid arthritis. Genet Mol Res 2013; 12: 328–334.

29.

Liu

Yang

Dai

Medzhitov

Freudenberg

Zhang

. TLR4 upregulation at protein or gene level is pathogenic for lupus-like autoimmune disease. J Immunol 2006; 177: 6880–6888.

30.

Lartigue

Colliou

Calbo

François

Jacquot

Arnoult

. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J Immunol 2009; 183: 6207–6216.

31.

Komatsuda

Wakui

Iwamoto

. Upregulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol 2008; 152: 482–487.

32.

Papadimitraki

Choulaki

Koutala

Bertsias

Tsatsanis

Gergianaki

. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: Implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 2006; 54: 3601–3611.

33.

Christensen

Shupe

Nickerson

Kashgarian

Flavell

Shlomchik

. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006; 25: 417–428.

34.

Connolly

O'Neill

. New developments in Toll-like receptor targeted therapeutics. Curr Opin Pharmacol 2012; 12: 510–518.

Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population – a preliminary report

Abstract

Objective

Methods

Results

Conclusion

Keywords

Get full access to this article

References